Acadia Healthcare Company Inc
$ 27.00
0.41%
17 Apr - close price
- Market Cap 2,479,575,000 USD
- Current Price $ 27.00
- High / Low $ 27.86 / 26.76
- Stock P/E N/A
- Book Value 21.55
- EPS -12.16
- Next Earning Report 2026-04-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE -0.41 %
- 52 Week High 28.48
- 52 Week Low 11.43
About
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.
Analyst Target Price
$23.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-25 | 2025-11-05 | 2025-07-29 | 2025-04-29 | 2025-02-25 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-02-27 | 2023-11-02 | 2023-07-27 | 2023-04-26 |
| Reported EPS | 0.07 | 0.72 | 0.83 | 0.4 | 0.64 | 0.91 | 0.91 | 0.84 | 0.85 | 0.91 | 0.92 | 0.75 |
| Estimated EPS | 0.1 | 0.67 | 0.7044 | 0.357 | 0.7146 | 0.9 | 0.87 | 0.81 | 0.79 | 0.89 | 0.86 | 0.71 |
| Surprise | -0.03 | 0.05 | 0.1256 | 0.043 | -0.0746 | 0.01 | 0.04 | 0.03 | 0.06 | 0.02 | 0.06 | 0.04 |
| Surprise Percentage | -30% | 7.4627% | 17.8308% | 12.0448% | -10.4394% | 1.1111% | 4.5977% | 3.7037% | 7.5949% | 2.2472% | 6.9767% | 5.6338% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-29 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.28 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ACHC
2026-04-16 06:39:22
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received an average "Hold" recommendation from sixteen analysts, with a consensus one-year price target of $21.15. The company recently surpassed quarterly earnings and revenue estimates and provided positive FY2026 guidance. Despite some banks raising price targets, the stock trades at mixed valuations, including a negative trailing P/E.
2026-04-15 12:10:20
Cantor Fitzgerald has reiterated a Neutral rating for Acadia Healthcare (NASDAQ:ACHC) with a price target of $20.00, which is below its current trading price of $26.56. The firm highlighted potential headwinds for healthcare providers in 2026 due to the Omnibus Budget Reconciliation Act of 2025, specifically citing Medicaid disenrollments and changes to the Disproportionate Share Hospital program and provider taxes. Despite the cautious outlook, recent developments for Acadia Healthcare include the appointment of Daniel Cancelmi to its board and positive Q4 earnings that surpassed analyst expectations, leading other firms like RBC Capital, Raymond James, and Leerink Partners to adjust price targets upwards.
2026-04-14 14:08:57
Implied volatility for Acadia Healthcare Company, Inc. (ACHC) stock options is surging, specifically for the May 15, 2026 $22.50 Call, indicating that the market expects significant movement in the stock. This surge in implied volatility, combined with Acadia Healthcare's Zacks Rank #3 (Hold) and positive consensus estimate revisions, suggests a potential trading opportunity according to analysts. Options traders often look to sell premium in such high implied volatility scenarios, anticipating that the underlying stock will not move as much as initially expected.
2026-04-14 13:09:42
Acadia Healthcare (ACHC) is facing scrutiny due to weak admissions, falling earnings, and higher capital needs, despite sustained demand for mental health treatment. A significant goodwill impairment and a projected net loss for 2025, combined with low same-facility volume growth guidance for 2026, suggest near-term challenges. This situation prompts a reevaluation of the company's long-term investment narrative, which previously projected substantial revenue and earnings growth.
2026-04-14 09:08:57
The global Behavioral Health Market is projected to grow from US$63.73 billion in 2024 to US$123.68 billion by 2033, exhibiting a CAGR of 7.5%. This growth is driven by increasing prevalence of mental health disorders, rising awareness, technological advancements in digital health, and supportive government initiatives, with depression being the dominant disorder segment and North America leading regional adoption. Key players like Acadia Healthcare and Universal Health Services are actively shaping the market through integrated care models and expanded services.
2026-04-13 20:39:05
Acadia Healthcare Company, Inc.'s Chief Financial Officer, Todd S. Young, was granted 58,799 shares of common stock as a compensation-related equity award on April 10, 2026. This grant, received at no cash cost, increases his direct holdings to 107,244 shares. The shares are scheduled to vest over three years in equal yearly installments starting April 10, 2027.
